Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 1999

Long term results of interferon alpha treatment in children with chronic hepatitis B

Dariusz M. Lebensztejn, Maciej Kaczmarski, Maria E. Sobaniec-Łotowska

Med Sci Monit 1999; 5(6): CR1129-1133 :: ID: 503159

Abstract

The aim of the study was a long-term evaluation of therapeutic efficiency of interferon alpha (IFN alpha) in children with diagnosed chronic hepatitis B (ch B). 79 children with the clinical and histopathological diagnosis of chronic hepatitis were subject to observation. The treatment with IFN alpha was applied to 55 children with HBs and HBe antigens persisting for over 6 months. Control group was formed of 24 children who did not receive IFN alpha. 12 months after the completion of treatment with IFN, the absence of HBV DNA polymerase in blood serum was recorded in 66% patients, 53% displayed HBeAg/antiHBeAg seroconversion and 7% patients manifested HBsAg/antiHBs seroconversion. HBeAg/antiHBe seroconversion occurred in 25% children from control group. 24 months after the end of treatment course, the absence of HBe antigen was recorded in 65% patients and the absence of HBs antigen - in 11% patients. 36 months after therapy completion, these values increased to 77% and 19% children receiving IFN alpha, respectively. The recurrence of HBV antigens was not observed in any of the analysed children.

Keywords: interferon alpha, children, HBV infection, chronic hepatitis

Add Comment 0 Comments

Editorial

01 November 2024 : Editorial  

Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and Prognosis

Dinah V. Parums

DOI: 10.12659/MSM.947038

Med Sci Monit 2024; 30:e947038

0:00

In Press

Animal Research  

Impact of Fresh Khat Extract on Proinflammatory Cytokines and Hepatic and Renal Responses

Med Sci Monit In Press; DOI: 10.12659/MSM.946108  

Review article  

Epigenetic and Immune Mechanisms Linking Breastfeeding to Lower Breast Cancer Rates

Med Sci Monit In Press; DOI: 10.12659/MSM.945451  

Clinical Research  

Comprehensive Analysis of Immune Infiltration and Key Genes in Peri-Implantitis Using Bioinformatics and Mo...

Med Sci Monit In Press; DOI: 10.12659/MSM.941870  

Clinical Research  

High-Resolution Anorectal Manometry and Balloon Expulsion Test Outcomes in Functional Constipation: A Compa...

Med Sci Monit In Press; DOI: 10.12659/MSM.944599  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,121,942

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,908,549

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   695,097

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

07 Jan 2022 : Meta-Analysis   259,824

Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...

DOI :10.12659/MSM.935074

Med Sci Monit 2022; 28:e935074

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750